These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38507101)

  • 1. Multiparametric Magnetic Resonance Imaging in the follow-up of non-muscle-invasive bladder tumors after intravesical instillations: a promising tool.
    Klein C; Brunelle S; Illy M; De Luca V; Doisy L; Lannes F; Sypre D; Branger N; Maubon T; Rybikowski S; Guérin M; Gravis G; Walz J; Pignot G
    World J Urol; 2024 Mar; 42(1):178. PubMed ID: 38507101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive studies may have potential to replace cystoscopy in non-muscle invasive bladder cancer follow-up.
    Lee J; Heo JE; Kang SK; Lee KS; Han H; Jang WS; Choi YD
    Sci Rep; 2022 Dec; 12(1):21677. PubMed ID: 36522359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablative Intravesical Chemotherapy for Small Recurrent Non-Muscle-Invasive Bladder Cancer: A Prospective Study.
    Decaestecker K; Lumen N; Ringoir A; Oosterlinck W
    Urol Int; 2016; 96(1):14-9. PubMed ID: 25791565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience.
    El-Assmy A; Abou-El-Ghar ME; Refaie HF; Mosbah A; El-Diasty T
    BJU Int; 2012 Dec; 110(11 Pt B):E622-7. PubMed ID: 22757606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparison of Different Prophylactic Intravesical Chemotherapy Regimens for Bladder Cancer Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinomas: A Retrospective 2-center Study.
    Huang Y; Cen J; Liu Z; Wei J; Chen Z; Feng Z; Lu J; Fang Y; Zhou F; Luo J; Mo C; Chen W
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819844483. PubMed ID: 30987527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial.
    Messing EM; Tangen CM; Lerner SP; Sahasrabudhe DM; Koppie TM; Wood DP; Mack PC; Svatek RS; Evans CP; Hafez KS; Culkin DJ; Brand TC; Karsh LI; Holzbeierlein JM; Wilson SS; Wu G; Plets M; Vogelzang NJ; Thompson IM
    JAMA; 2018 May; 319(18):1880-1888. PubMed ID: 29801011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidental bladder cancers found on multiparametric MRI of the prostate gland: a single center experience.
    Rayn KN; Hale GR; Bloom JB; Gold SA; Carvalho FLF; Mehralivand S; Czarniecki M; Wood BJ; Merino MJ; Choyke P; Türkbey B; Pinto PA; Agarwal PK
    Diagn Interv Radiol; 2018 Sep; 24(5):316-320. PubMed ID: 30211685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
    Babjuk M; Böhle A; Burger M; Capoun O; Cohen D; Compérat EM; Hernández V; Kaasinen E; Palou J; Rouprêt M; van Rhijn BWG; Shariat SF; Soukup V; Sylvester RJ; Zigeuner R
    Eur Urol; 2017 Mar; 71(3):447-461. PubMed ID: 27324428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Single, immediate postoperative intra-vesical instillation (SI) compared to a single preoperative intra-vesical instillation of mitomycin C in non-muscle invasive bladder cancer (NMIBC). Phase II randomized trial].
    Breton J; Bernardeau S; Vallée M; Pillot P; Lebacle C; Delpech PO; Charles T; Biscans C; Vallat A; Pfister C; Irani J
    Prog Urol; 2021 Feb; 31(2):63-70. PubMed ID: 32891506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the effectiveness between long-term instillation of mitomycin C and short-term prophylaxis with MMC or bacille Calmette-Guérin. Study of patients with non-muscle-invasive urothelial cancer of the urinary bladder].
    Isbarn H; Budäus L; Pichlmeier U; Conrad S; Huland H; Friedrich MG
    Urologe A; 2008 May; 47(5):608-15. PubMed ID: 18317718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indication for a Single Postoperative Instillation of Chemotherapy in Non-muscle-invasive Bladder Cancer: What Factors Should Be Considered?
    Babjuk M; Burger M; Compérat EM; Gontero P; Mostafid HA; Palou J; van Rhijn BWG; Rouprêt M; Shariat SF; Sylvester R; Zigeuner R; Capoun O; Cohen D; Dominguez-Escrig JL; Hernández V; Peyronnet B; Seisen T; Soukup V;
    Eur Urol Focus; 2018 Jul; 4(4):525-528. PubMed ID: 30061076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)?
    Geavlete B; Multescu R; Georgescu D; Jecu M; Stanescu F; Geavlete P
    BJU Int; 2012 Feb; 109(4):549-56. PubMed ID: 21711438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decision Based on Narrow Band Imaging Cystoscopy without a Referential Normal Standard Rather Increases Unnecessary Biopsy in Detection of Recurrent Bladder Urothelial Carcinoma Early after Intravesical Instillation.
    Song PH; Cho S; Ko YH
    Cancer Res Treat; 2016 Jan; 48(1):273-80. PubMed ID: 25761489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intravesical instillations on the human complement factor H related protein (BTA stat) test.
    Raitanen MP; Hellström P; Marttila T; Korhonen H; Talja M; Ervasti J; Tammela TL;
    Eur Urol; 2001 Oct; 40(4):422-6. PubMed ID: 11713397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine cytology is a feasible tool for assessing erythematous bladder lesions after bacille Calmette-Guérin (BCG) treatment.
    Nurminen P; Ettala O; Seppänen M; Taimen P; Boström PJ; Kaipia A
    BJU Int; 2019 Feb; 123(2):246-251. PubMed ID: 29959824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of intravesical therapy for non-muscle invasive bladder cancer on the accuracy of urine cytology.
    Gupta M; Milbar N; Tema G; Pederzoli F; Chappidi M; Kates M; VandenBussche CJ; Bivalacqua TJ
    World J Urol; 2019 Oct; 37(10):2051-2058. PubMed ID: 30671639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HELENA study: Hexvix
    Gierth M; Breyer J; Zeman F; Fritsche HM; Cordes J; Karl A; Zaak D; Stenzl A; von Schmeling IK; Sommerhuber A; Zierer T; Burger M; Mayr R
    World J Urol; 2021 Oct; 39(10):3799-3805. PubMed ID: 34002265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three schedules of intravesical epirubicin in patients with non-muscle-invasive bladder cancer.
    Hendricksen K; Witjes WP; Idema JG; Kums JJ; van Vierssen Trip OB; de Bruin MJ; Vergunst H; Caris CT; Janzing-Pastors MH; Witjes JA
    Eur Urol; 2008 May; 53(5):984-91. PubMed ID: 18248876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of early failures after intravesical instillation therapy with bacille Calmette-Guérin for carcinoma in situ of the bladder.
    Merz VW; Marth D; Kraft R; Ackermann DK; Zingg EJ; Studer UE
    Br J Urol; 1995 Feb; 75(2):180-4. PubMed ID: 7850322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II multi-center trial of optical coherence tomography as an adjunct to white light cystoscopy for intravesical real time imaging and staging of bladder cancer.
    Sung HH; Scherr DS; Slaton J; Liu H; Feeny KL; Lingley-Papadopoulos C; Gearheart J; Zara JM; Lerner SP
    Urol Oncol; 2021 Jul; 39(7):434.e23-434.e29. PubMed ID: 33934964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.